Table 1 SNPs investigated in AC pharmacogenetics study

From: Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide

Gene

Ref SNP ID

Genotype

Mutation

ABCB1

 Exon 12

1128503

C1236T

Synonymous

 Exon 21

2032582

G2677T/A

Ala893Ser/Thr

 Exon 26

1045642

C3435T

Synonymous

SLC22A16

 Exon 2

714368

A146G

His49Arg

 Exon 2

6907567

T312C

Synonymous

 Exon 4

723685

T755C

Val252Ala

 Exon 5

12210538

T1226C

Met409Thr

CYP2B6

 *2

8192709

C64T

Arg22Cys

 *8

12721655

A415G

Lys139Glu

 *9

3745274

G516T

Gln172His

 *3

45482602

C777A

Ser259Arg

 *4

2279343

A785G

Lys262Arg

 *5

3211371

C1459T

Arg487Cys

CYP2C9

 *2

1799853

C430T

Arg144Cys

 *3

1057910

A1075C

Ile359Leu

CYP3A5

 *3

776746

A6986G

Splice variant

CYP2C19

 *2

4244285

G681A

Splice variant

  1. Abbreviation: AC=doxorubicin and cyclophosphamide.